Literature DB >> 3561153

A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats.

K S Estes, M E Brewster, J W Simpkins, N Bodor.   

Abstract

A series of 4 studies was conducted to examine the estrogen-like activity of a chemical delivery system (CDS) coupled to estradiol (E2). The CDS is based on a redox system, analogous to the NAD+ in equilibrium NADH coenzyme system and has previously been shown capable of sustained and site specific drug delivery to the central nervous system. The ability of CDS-E2 to suppress luteinizing hormone (LH) in gonadectomized rats was examined as an index of sustained estrogen action. A single dose of CDS-E2 resulted in significantly decreased LH serum levels in castrate rats through at least 24 days while an equimolar dose of E2 resulted in only transient LH decrease. Serum E2 levels were not different between the treatment groups, indicating that peripheral estrogen could not readily explain sustained hormone activity. A dose-response relationship was observed 12 days post-drug treatment in all monitored estrogen activities which showed CDS-E2 is more potent compared to equimolar E2. Further, LH suppression was significantly greater compared to ovariectomized rats treated with equimolar estradiol valerate, while anterior pituitary weights were not different between groups. Together with our previous data, these studies show that CDS-E2 exerts sustained estrogen-like activity which cannot be readily attributed to circulating E2 levels. These findings are consistent with a sustained, brain directed delivery of estrogen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3561153     DOI: 10.1016/0024-3205(87)90590-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  A redox-based system that enhances delivery of estradiol to the brain: pharmacokinetic evaluation in the dog.

Authors:  K Dietzel; V Keuth; K S Estes; M E Brewster; R M Clemmons; R Vistelle; N S Bodor; H Derendorf
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 2.  Prodrug approaches for CNS delivery.

Authors:  Jarkko Rautio; Krista Laine; Mikko Gynther; Jouko Savolainen
Journal:  AAPS J       Date:  2008-02-05       Impact factor: 4.009

3.  A redox-based chemical delivery system that enhances estradiol distribution to the brain: disposition studies in the rat.

Authors:  K S Estes; V Keuth; K Dietzel; M E Brewster; N S Bodor; H Derendorf
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

4.  High-performance liquid chromatographic assay of a central nervous system (CNS)-directed estradiol chemical delivery system and its application after intravenous administration to rats.

Authors:  G Mullersman; H Derendorf; M E Brewster; K S Estes; N Bodor
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

5.  Growth hormone (GH) secretory dynamics in animals administered estradiol utilizing a chemical delivery system.

Authors:  W J Millard; T M Romano; N Bodor; J W Simpkins
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

6.  Effects of a brain-enhanced chemical delivery system for estradiol on body weight and food intake in intact and ovariectomized rats.

Authors:  J W Simpkins; W R Anderson; R Dawson; N Bodor
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.